April 3, 2019 / Last updated : April 3, 2019 Benjamin Clark Medical

Universal Health Services Inc Valuation – April 2019 #UHS

Universal Health Services, Inc. Class B qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the low current ratio.

March 23, 2019 / Last updated : March 23, 2019 Benjamin Clark Medical

Dentsply Sirona Inc Valuation – March 2019 #XRAY

DENTSPLY SIRONA Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.

March 21, 2019 / Last updated : March 21, 2019 Benjamin Clark Medical

McKesson Corp Valuation – March 2019 #MCK

McKesson Corporation qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the low current ratio.

March 21, 2019 / Last updated : March 21, 2019 Benjamin Clark Medical

IDEXX Laboratories Inc Valuation – March 2019 #IDXX

IDEXX Laboratories, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, poor dividend history, and the high PEmg and PB ratios.

March 20, 2019 / Last updated : March 20, 2019 Benjamin Clark Medical

Hologic Inc Valuation – March 2019 #HOLX

Hologic, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

March 18, 2019 / Last updated : March 18, 2019 Benjamin Clark Medical

Mettler-Toledo International Inc Valuation – March 2019 #MTD

Mettler-Toledo International Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, poor dividend history, and the high PEmg and PB ratios.

March 13, 2019 / Last updated : March 13, 2019 Benjamin Clark Medical

DaVita Inc Valuation – March 2019 #DVA

Davita Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the poor dividend history.

March 12, 2019 / Last updated : March 12, 2019 Benjamin Clark Medical

Danaher Corp Valuation – March 2019 #DHR

Danaher Corporation does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

March 9, 2019 / Last updated : March 9, 2019 Benjamin Clark Medical

Agilent Technologies Inc Valuation – March 2019 #A

Agilent Technologies Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

March 8, 2019 / Last updated : March 8, 2019 Benjamin Clark Medical

ResMed Inc Valuation – March 2019 #RMD

ResMed Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios.